PURPLE BIOTECH LTD. Amended Reports
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-03-16: Form 20-F/A; Period of report 2020-12-31; Description AMENDMENT NO. 1 TO FORM 20-F; Document f20f2020a1_purplebiotech.htm.
- 2020-03-31: Form 20-F/A; Period of report 2019-12-31; Description AMENDMENT NO.1 TO FORM 20-F; Document f20f2019a1_kitovpharma.htm.
- 2019-04-03: Form 20-F/A; Period of report 2018-12-31; Description AMENDMENT NO. 1 TO FORM 20-F; Document f20f2018a1_kitovpharmaltd.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-03-16 | 20-F/A | 2020-12-31 | AMENDMENT NO. 1 TO FORM 20-F | f20f2020a1_purplebiotech.htm |
| 2020-03-31 | 20-F/A | 2019-12-31 | AMENDMENT NO.1 TO FORM 20-F | f20f2019a1_kitovpharma.htm |
| 2019-04-03 | 20-F/A | 2018-12-31 | AMENDMENT NO. 1 TO FORM 20-F | f20f2018a1_kitovpharmaltd.htm |